SCHEMBL3485822

SCHEMBL3485822

Nc1nnc2ccccc2c1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.59
▸ KDM4E B2RXH2 7/20 0.56
▸ HSD17B10 Q99714 8/20 0.56
▸ ALDH1A1 P00352 7/20 0.56
▸ ACHE P22303 5/20 0.56
▸ HPGD P15428 3/20 0.56
▸ GLA P06280 2/20 0.56
▸ CASP1 P29466 2/20 0.56
▸ CASP7 P55210 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ CHRM2 P08172 2/20 0.56
▸ ADRA2A P08913 2/20 0.56
▸ ADORA3 P0DMS8 2/20 0.56
▸ CHRM1 P11229 2/20 0.56
▸ SLC6A2 P23975 2/20 0.56
▸ OPRM1 P35372 2/20 0.56
▸ KCNH2 Q12809 2/20 0.56
▸ NQO2 P16083 1/20 0.56
▸ MAOA P21397 1/20 0.56
▸ DRD1 P21728 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22776964 0.77 GPR3 (0.54) GPR3KDM4EHSD17B10ALDH1A1ACHE
SCHEMBL11732580 0.77 GPR3 (0.54) GPR3KDM4EHSD17B10ALDH1A1ACHE
Benzonaphthyridine SCHEMBL51197 0.76 GPR3 (1.00) GPR3KDM4EHSD17B10ALDH1A1ACHE
Benzonaphthyridine SCHEMBL29600756 0.76 GPR3 (1.00) GPR3KDM4EHSD17B10ALDH1A1ACHE
Benzonaphthyridine SCHEMBL30897319 0.76 GPR3 (1.00) GPR3KDM4EHSD17B10ALDH1A1ACHE
SCHEMBL221530 0.73 KDM4E (1.00) GPR3KDM4EHSD17B10ALDH1A1ACHE
SCHEMBL31416835 0.73 KDM4E (1.00) GPR3KDM4EHSD17B10ALDH1A1ACHE
SCHEMBL9496321 0.73 LCK (0.77) GPR3KDM4EHSD17B10ALDH1A1ACHE
SCHEMBL20301264 0.73 KDM4E (0.48) GPR3KDM4EHSD17B10ALDH1A1ACHE
Aminacrine SCHEMBL29354393 0.72 HSD17B10 (1.00) KDM4EHSD17B10ALDH1A1ACHEHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257536-A2 CYCLIC DIARYL ETHER AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS Amira Pharmaceuticals, Inc. (US) 2010-12-08 — — EP disclosed
WO-2009102893-A2 CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors AMIRA PHARMACEUTICALS, INC. (US) 2009-08-20 — — WO disclosed
Send feedback